| Amanta Healthcare Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 544502 |
NSE Symbol : AMANTA |
P/E(TTM) : 40.93 |
|
ISIN Demat : INE084K01015 |
Div & Yield% : 0.00 |
EPS(TTM) : 4.23 |
|
Book Value(₹) : 56.71 |
Market Cap(₹Cr) : 672.33 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 68.80 | 76.99 | 74.49 | 70.89 | 65.31 | 72.06 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 68.80 | 76.99 | 74.49 | 70.89 | 65.31 | 72.06 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.64 | 1.66 | 0.68 | 0.07 | 0.96 | 0.16 |
| Total Income | 69.45 | 78.66 | 75.16 | 70.96 | 66.27 | 72.22 |
| Total Expenditure | 54.26 | 62.04 | 59.13 | 58.87 | 50.41 | 53.10 |
| PBIDT | 15.18 | 16.61 | 16.04 | 12.09 | 15.85 | 19.13 |
| Interest | 6.00 | 4.25 | 5.06 | 5.15 | 6.29 | 6.28 |
| PBDT | 9.18 | 12.37 | 10.98 | 6.94 | 9.57 | 12.84 |
| Depreciation | 4.69 | 4.75 | 4.67 | 4.66 | 4.64 | 4.69 |
| Tax | 0.35 | 2.93 | 2.04 | 1.97 | 1.65 | 1.81 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.83 | -0.84 | -0.37 | -0.90 | -0.23 | 0.38 |
| Reported Profit After Tax | 3.31 | 5.53 | 4.63 | 1.21 | 3.51 | 5.96 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | -0.66 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 3.31 | 5.53 | 4.63 | 1.87 | 3.51 | 5.96 |
| EPS (Unit Curr.) | 0.85 | 1.61 | 1.35 | 0.35 | 1.22 | 2.11 |
| EPS (Adj) (Unit Curr.) | 0.85 | 1.61 | 1.35 | 0.35 | 1.22 | 2.11 |
| Calculated EPS (Unit Curr.) | 0.85 | 1.42 | 1.19 | 0.31 | 1.22 | 2.07 |
| Calculated EPS (Adj) (Unit Curr.) | 0.85 | 1.42 | 1.19 | 0.31 | 1.22 | 2.07 |
| Calculated EPS (Ann.) (Unit Curr.) | 3.41 | 5.70 | 4.77 | 1.24 | 4.87 | 8.27 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 3.41 | 5.70 | 4.77 | 1.24 | 4.87 | 8.27 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 38.83 | 38.83 | 38.83 | 38.83 | 28.83 | 28.83 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 22.06 | 21.57 | 21.53 | 17.05 | 24.27 | 26.55 |
| PBDTM(%) | 13.34 | 16.07 | 14.74 | 9.79 | 14.65 | 17.82 |
| PATM(%) | 4.81 | 7.18 | 6.22 | 1.71 | 5.37 | 8.27 |
